BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16267566)

  • 1. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats.
    Seppen J; van Til NP; van der Rijt R; Hiralall JK; Kunne C; Elferink RP
    Gene Ther; 2006 Apr; 13(8):672-7. PubMed ID: 16267566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
    Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
    Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.
    Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P
    Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer.
    Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N
    Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.
    Nguyen TH; Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trono D; Ferry N
    Mol Ther; 2005 Nov; 12(5):852-9. PubMed ID: 16140582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector.
    van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ
    Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.
    Li Q; Murphree SS; Willer SS; Bolli R; French BA
    Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable correction of inherited metabolic liver disorders requires preventing transgene off-targeting from gene therapy vectors: the value of microRNAs.
    Gonzalez-Aseguinolaza G; Prieto J
    Gastroenterology; 2010 Sep; 139(3):726-9. PubMed ID: 20655958
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.
    Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trivin F; Ferry N
    Hepatology; 2005 Aug; 42(2):431-8. PubMed ID: 16025517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK; Hitomi Y; Mao M; Wilson JM
    Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
    Montenegro-Miranda PS; Sneitz N; de Waart DR; Ten Bloemendaal L; Duijst S; de Knegt RJ; Beuers U; Finel M; Bosma PJ
    Biochim Biophys Acta; 2012 Aug; 1822(8):1223-9. PubMed ID: 22546842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for inherited hyperbilirubinemias.
    Roy-Chowdhury N; Kadakol A; Sappal BS; Thummala NR; Ghosh SS; Lee SW; Roy-Chowdhury J
    J Perinatol; 2001 Dec; 21 Suppl 1():S114-8; discussion S125-7. PubMed ID: 11803431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle.
    Pastore N; Nusco E; Vaníkova J; Sepe RM; Vetrini F; McDonagh A; Auricchio A; Vitek L; Brunetti-Pierri N
    Hum Gene Ther; 2012 Oct; 23(10):1082-9. PubMed ID: 22765254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.
    Dankó I; Jia Z; Zhang G
    Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer.
    Seppen J; van der Rijt R; Looije N; van Til NP; Lamers WH; Oude Elferink RP
    Mol Ther; 2003 Oct; 8(4):593-9. PubMed ID: 14529832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation.
    Seppen J; Tada K; Ottenhoff R; Sengupta K; Chowdhury NR; Chowdhury JR; Bosma PJ; Oude Elferink RP
    Hum Gene Ther; 1997 Jan; 8(1):27-36. PubMed ID: 8989992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
    Montenegro-Miranda PS; Pichard V; Aubert D; Ten Bloemendaal L; Duijst S; de Waart DR; Ferry N; Bosma PJ
    Gene Ther; 2014 Feb; 21(2):168-74. PubMed ID: 24285217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A step toward liver gene therapy: efficient correction of the genetic defect of hepatocytes isolated from a patient with Crigler-Najjar syndrome type 1 with lentiviral vectors.
    Birraux J; Menzel O; Wildhaber B; Jond C; Nguyen TH; Chardot C
    Transplantation; 2009 Apr; 87(7):1006-12. PubMed ID: 19352119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.